Partner Content Partner Content Disruptive Technologies in Pharma 2020 - the "Healthcare Dis... AI in Pharma
Partner Content Partner Content Interview with OnDigital Health Consulting ahead of Disrupti... SMi is delighted to present the launch of the Disruptive Technologies in Pharma conference taking place on the 20th – 21st January 2020, in London.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
